Quarterly report pursuant to Section 13 or 15(d)

ISSUANCE OF EQUITY INTERESTS (Details)

v3.22.2.2
ISSUANCE OF EQUITY INTERESTS (Details) - USD ($)
 3 Months Ended 9 Months Ended
Jul. 27, 2022
Jul. 25, 2022
Jun. 29, 2021
Sep. 30, 2022
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Jun. 23, 2021
Jan. 31, 2021
Equity                  
Common stock, Authorized (in shares)       200,000,000 200,000,000   200,000,000 200,000,000  
Common stock, Outstanding (in shares)       11,592,609 11,592,609   10,215,792    
Shares issued during the period     2,875,000            
Purchase price (in dollars per share)     $ 6.00            
Proceeds from Initial Public Offering, net of issuance costs     $ 14,800,000     $ 14,797,132      
Cash issuance cost     2,400,000 $ 529,805          
Common stock, par value       $ 0.001 $ 0.001   $ 0.001    
Stock issue gross proceeds     $ 17,300,000            
Proceeds from stock issue, net of costs         $ 3,695,183        
Members' Equity, Class A and Class B                  
Equity                  
Converted to shares of common stock     14,082,318            
Converted shares of common stock     7,041,208            
Members' Equity, Class A                  
Equity                  
Purchase price (in dollars per share)                 $ 3.25
Number of warrants     1,437,577            
Warrant exercise price (in dollars per share)     $ 2.88            
Members' Equity, Class B                  
Equity                  
Purchase price (in dollars per share)                 $ 3.25
Underwriter                  
Equity                  
Number of warrants     150,000            
Warrant exercise price (in dollars per share)     $ 7.50            
Warrant exercisable term     4 years 6 months            
Registered direct offering                  
Equity                  
Shares issued during the period 1,159,211 1,159,211              
Common stock, par value   $ 0.001              
Pre-funded Warrant Exercise (in shares) 130,769 130,769              
Stock issue gross proceeds $ 4,200,000 $ 4,200,000              
Proceeds from stock issue, net of costs   $ 3,700,000              
Registered direct offering | Series A warrants                  
Equity                  
Number of warrants   1,289,980              
Registered direct offering | Series B warrants                  
Equity                  
Number of warrants   1,289,980              
Registered direct offering | Affiliate Investors                  
Equity                  
Shares issued during the period   59,211              
Purchase price (in dollars per share)   $ 3.80              
Warrant exercise price (in dollars per share)   $ 3.55              
Registered direct offering | Affiliate Investors | Series A warrants                  
Equity                  
Number of warrants   59,211              
Registered direct offering | Affiliate Investors | Series B warrants                  
Equity                  
Number of warrants   59,211              
Registered direct offering | Investor                  
Equity                  
Shares issued during the period   1,100,000              
Purchase price (in dollars per share)   $ 3.25              
Warrant exercise price (in dollars per share)   $ 0.0001              
Pre-funded Warrant Exercise (in shares)   130,769              
Purchase price pre-funded warrant (in dollars per share)   $ 3.2499              
Registered direct offering | Investor | Series A warrants                  
Equity                  
Number of warrants   1,230,769              
Registered direct offering | Investor | Series B warrants                  
Equity                  
Number of warrants   1,230,769              
Warrant exercise price (in dollars per share)   $ 3.25              
Placement Agents                  
Equity                  
Cash issuance cost   $ 287,874              
Number of warrants   63,018              
Warrant exercise price (in dollars per share)   $ 3.60              
Weighted average aggregate offering price (as a percent)   110.00%